We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Local studies have prompted concerns over the safety of
Israeli generic major Teva's Copaxone (glatiramer acetate injection) product,
indicated for muscular degenerative disorder multiple sclerosis (MS).
The Brazilian unit of Netherlands- and US-based drugmaker
Organon has reportedly announced new product partnerships with local drugmakers
Cristalia and EMS.
Japanese drugmaker Eisai has announced that following the failure of discussions
with distribution partner Cardinal Health, the latter company's position as
distributor of record for its US product lines is to end.
Israel-based generics major Teva has announced that the abbreviated new drug
application for its injectable antifungal Fluconazole has received final US
FDA approval.
According to local sources, the Iranian government is shortly to
introduce new quality checks on a number of imported products, including pharmaceuticals.
Although Argentina's pharmaceuticals market is widely estimated to
have stabilised in recent months, following the country's comparatively rapid
recovery from its recent economic crisis, regulatory reform appears deadlocked.